DioGenX
Marseille, France · diogenx.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
DiogenX is a preclinical-stage biotech company focused on developing biologics for diabetes, especially treatments aimed at regenerating insulin-producing beta cells. It is based in Marseille, France, with research labs in Nice, France.
Their website has a general contact form; we send your quote request through it.
What they offer
Discovery and development of biologics for diabetes
Develops innovative biologics as therapeutic options for diabetes patients.
Regenerative therapy development for type 1 diabetes
Advances a first-in-class regenerative treatment approach for type 1 diabetes.
Beta cell regeneration research
Works on regenerating insulin-producing pancreatic beta cells for diabetes treatment.
Recombinant protein development
Develops first-in-class recombinant proteins designed for the treatment of type 1 diabetes.
What they work on
- Modalities
- Recombinant protein
- Therapeutic areas
- diabetes, type 1 diabetes
- Sites
- Marseille, France · Nice, France
- Founded
- 2020
Public records
- Ownership
- DIOGENX · FR GLEIF
Similar labs. 1st BASE, 3C Therapeutics, Abeomics, Abnova
Found in a contract services directory. Listing built from diogenx.com. Work here? Claim this listing.